This video interview highlights the prevalence and impact of dry eye disease. The impact of this disease of these groups will be discussed: Ocular Surface Disease patients, Cataract and refractive surgery patients, Contact lens dropout patients.
This activity is supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea.
Upon completion of this activity, the participant should be able to:
Sponsored by: 
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 123850, is accredited by COPE for continuing education for optometrists for .25 hours.
Course #: 78199-TD
Activity #: 123850
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Marc R. Bloomenstein, OD, FAAO
Schwartz Laser Eye Center
Director of Optometric Services
Scottsdale, AZ
Cecelia C. Koetting, OD, FAAO
Hines Sight
Denver, CO
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Marc R. Bloomenstein, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, Azura, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OcuSoft, Sight Sciences, Sun Pharmaceutical Industries, and Tarsus. Grant/Research Support: Sight Sciences. Speaker’s Bureau: Allergan, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OysterPoint, RVL, Sight Sciences, and Sun Pharmaceutical Industries.
Cecelia C. Koetting, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Grant/Research: Johnson & Johnson Vision. Consultant: Alcon, Allergan, Bruder, Dompé, Eyevance, Glaukos, Kala Pharmaceuticals, Ivantis, Orasis, OysterPoint, RVL, Tarsus, and Visus. Speaker's Bureau: Alcon, Dompé, Eyevance, Ivantis, OysterPoint, and RVL.
The Evolve and The Fundingsland Group staff and planners have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, or Thea.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
